Prestigious U.S. grant to advance viral therapy for brain cancer

November 20, 2013

Dr. John Bell has received the 2013 Investigator Award from the Alliance for Cancer Gene Therapy, a highly-competitive $500,000 grant awarded to a single scientist / team from the U.S. or Canada. The grant will enable Dr. Bell and his colleagues to develop a manufacturing process for a novel cancer-fighting virus (called Chimeric Maraba), which has been shown to be particularly safe and effective in animal models of brain cancer.

Partners on the grant include Drs. David Stojdl from CHEO / uOttawa, Dr. Andrea McCart from the University Health Network / UofT and Dr. Lawton Stubbert from OHRI / uOttawa.

About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.

Media contact
Jennifer Ganton
Director, Communications and Public Relations
Ottawa Hospital Research Institute
613-798-5555 x 73325
613-614-5253 (cell)